Donald L. Harrison

1.2k total citations
66 papers, 645 citations indexed

About

Donald L. Harrison is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Economics and Econometrics. According to data from OpenAlex, Donald L. Harrison has authored 66 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Geriatrics and Gerontology, 15 papers in Pediatrics, Perinatology and Child Health and 12 papers in Economics and Econometrics. Recurrent topics in Donald L. Harrison's work include Pharmaceutical Practices and Patient Outcomes (21 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Pediatric Pain Management Techniques (7 papers). Donald L. Harrison is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (21 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Pediatric Pain Management Techniques (7 papers). Donald L. Harrison collaborates with scholars based in United States, United Kingdom and Malawi. Donald L. Harrison's co-authors include Peter N. Johnson, Michael J. Miller, Jamie L. Miller, Michael R. Schmitt, J. Lyle Bootman, Kevin C. Farmer, Susan E. Fugate, Tracy M. Hagemann, Toni L. Ripley and Jeffrey C. Jolley and has published in prestigious journals such as Psychiatric Services, Nephrology Dialysis Transplantation and Patient Education and Counseling.

In The Last Decade

Donald L. Harrison

66 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald L. Harrison United States 15 180 103 98 80 70 66 645
Kem P. Krueger United States 10 227 1.3× 91 0.9× 99 1.0× 100 1.3× 109 1.6× 26 693
Kathleen A. Fairman United States 15 172 1.0× 132 1.3× 93 0.9× 314 3.9× 79 1.1× 56 963
Nancy L. Dawson United States 16 96 0.5× 36 0.3× 154 1.6× 33 0.4× 138 2.0× 43 696
Lisa Bishop Canada 14 149 0.8× 79 0.8× 206 2.1× 52 0.7× 70 1.0× 63 755
Peter E. Wu Canada 13 98 0.5× 36 0.3× 193 2.0× 82 1.0× 38 0.5× 50 649
Kenneth M. Flegel Canada 13 100 0.6× 81 0.8× 117 1.2× 65 0.8× 120 1.7× 31 672
Brian Doyle United States 10 91 0.5× 58 0.6× 141 1.4× 65 0.8× 51 0.7× 24 590
Surrey M. Walton United States 12 107 0.6× 113 1.1× 96 1.0× 125 1.6× 58 0.8× 21 635
Gyöngyvér Soós Hungary 12 115 0.6× 78 0.8× 63 0.6× 57 0.7× 33 0.5× 39 445
Michael Peters United States 7 354 2.0× 84 0.8× 68 0.7× 51 0.6× 50 0.7× 19 566

Countries citing papers authored by Donald L. Harrison

Since Specialization
Citations

This map shows the geographic impact of Donald L. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald L. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald L. Harrison more than expected).

Fields of papers citing papers by Donald L. Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald L. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald L. Harrison. The network helps show where Donald L. Harrison may publish in the future.

Co-authorship network of co-authors of Donald L. Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Donald L. Harrison. A scholar is included among the top collaborators of Donald L. Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald L. Harrison. Donald L. Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Peter N., et al.. (2016). Initial Dosing and Taper Complexity of Methadone and Morphine for Treatment of Neonatal Abstinence Syndrome. Journal of Pharmacy Technology. 32(5). 216–222. 2 indexed citations
2.
Smith, Michael J., et al.. (2015). Prior authorization policies in Medicaid programs: The importance of study design and analysis on findings and outcomes from research. Research in Social and Administrative Pharmacy. 12(1). 154–163. 3 indexed citations
3.
Mittal, Manish, Donald L. Harrison, David M. Thompson, et al.. (2015). An evaluation of three statistical estimation methods for assessing health policy effects on prescription drug claims. Research in Social and Administrative Pharmacy. 12(1). 29–40. 2 indexed citations
4.
Brahm, Nancy C., et al.. (2013). Mental Health Treatment Associated with Community-Based Depression Screening: Considerations for Planning Multidisciplinary Collaborative Care. Annals of Pharmacotherapy. 47(6). 797–804. 3 indexed citations
5.
Mittal, Manish, Donald L. Harrison, Michael J. Miller, & Nancy C. Brahm. (2013). National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warning. Research in Social and Administrative Pharmacy. 10(5). 781–790. 11 indexed citations
6.
Johnson, Peter N., et al.. (2012). A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home. Research in Social and Administrative Pharmacy. 8(5). 455–463. 4 indexed citations
7.
Smith, Marcus J., et al.. (2012). Warfarin Management Using Point-of-Care Testing in a University-Based Internal Medicine Resident Clinic. The American Journal of the Medical Sciences. 344(4). 289–293. 5 indexed citations
8.
Johnson, Peter N., Donald L. Harrison, & Christine Allen. (2011). Utility of transdermal fentanyl for prevention of iatrogenic opioid abstinence syndrome in children. Journal of Opioid Management. 6(2). 117–124. 6 indexed citations
9.
Britton, Mark L., et al.. (2011). Assessing the need for diabetes self-management education in the Oklahoma city vietnamese community. Diabetes Therapy. 2(2). 81–91. 7 indexed citations
10.
Schmitt, Michael R., Michael J. Miller, Donald L. Harrison, et al.. (2010). Communicating non-steroidal anti-inflammatory drug risks: Verbal counseling, written medicine information, and patients’ risk awareness. Patient Education and Counseling. 83(3). 391–397. 33 indexed citations
11.
Marcy, Todd R., et al.. (2010). Medication reconciliation in a community pharmacy setting. Journal of the American Pharmacists Association. 50(4). 523–526. 30 indexed citations
12.
Schmitt, Michael R., et al.. (2010). Relationship of Depression Screening and Physician Office Visit Duration in a National Sample. Psychiatric Services. 61(11). 1126–1131. 18 indexed citations
13.
14.
Harrison, Donald L., et al.. (2009). Economic effect of an expansion of pharmacy benefits on total health care expenditures by a state Medicaid program. Journal of the American Pharmacists Association. 49(6). 744–750. 1 indexed citations
15.
Harrison, Donald L., et al.. (2007). Disparities in the Prevalence of Medication Therapy for Hyperlipidemia in the Elderly. The Consultant Pharmacist. 22(10). 847–854. 1 indexed citations
16.
Harrison, Donald L., et al.. (2006). Predicting the impact of Medicare Part D implementation on the pharmacy workforce. Research in Social and Administrative Pharmacy. 2(3). 315–328. 3 indexed citations
17.
Harrison, Donald L.. (1997). Levels of Independent Community Pharmacy Strategic Planning. Journal of Pharmaceutical Marketing & Management. 11(4). 21–34. 1 indexed citations
18.
Harrison, Donald L.. (1996). Cost-effectiveness of Regional Poison Control Centers. Archives of Internal Medicine. 156(22). 2601–2601. 35 indexed citations
19.
Harrison, Donald L. & J. Lyle Bootman. (1990). Strategic Planning for Institutional Pharmacy Administrators. Journal of Pharmaceutical Marketing & Management. 5(1). 29–43. 8 indexed citations
20.
Harrison, Donald L., et al.. (1989). Fructosamines in Uraemia and Renal Replacement Therapy. Nephrology Dialysis Transplantation. 4(8). 748–749. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kem P. Krueger Breakdown of academic impact, for papers by Kathleen A. Fairman Breakdown of academic impact, for papers by Nancy L. Dawson Breakdown of academic impact, for papers by Lisa Bishop Breakdown of academic impact, for papers by Peter E. Wu Breakdown of academic impact, for papers by Kenneth M. Flegel Breakdown of academic impact, for papers by Brian Doyle Breakdown of academic impact, for papers by Surrey M. Walton Breakdown of academic impact, for papers by Gyöngyvér Soós Breakdown of academic impact, for papers by Michael Peters
Rankless by CCL
2026